💬 Thank you, ISPOR—The Professional Society for Health Economics and Outcomes Research for the posters, panels, and perspectives
Our team returns from ISPOREurope full of insights and gratitude.
â– Gratitude for the collaborative conversations, the thought-provoking sessions, and the many colleagues and clients we connected with in-person.
We especially appreciated discussions around:
• The evolving impact of EU JCA
•  Linking RWE to sustainable access
•  New perspectives on patient-centred value
•  And the questions raised in every Q&A
đź“Š We were also proud to co-author three client-led posters presented at the conference, highlighting impactful research grounded in Nordic data:
🔹 Myelofibrosis treatment patterns in Denmark and Sweden
🔹 Glycaemic control and real-world costs in Swedish T2D
🔹 Long-term income impacts in working-age glioma patients
Special thanks to our colleagues from the athagoras Group, IGES Pharma, and IGES MedTech for the shared moments and meaningful exchanges throughout the week.
These collaborations are a reminder of how real-world evidence, done rigorously, supports better policy, access, and outcomes.
🤔 What topic or session stuck with you most from ISPOR?
